Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nerispirdine on visual function in multiple sclerosis
NCT00772525Phase 2Completed
- Sponsor
- Sanofi
- Start
- Sep 2008
- Primary completion
- Jun 2009
- Modality
- Multivalent & Scaffold-Based Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nerispirdine in multiple sclerosis (MS), sponsored by Sanofi. Started Sep 2008; status: completed.
02
Drugs
nerispirdine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00772525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00772525.